EQUIFAX INC
In the published model solve dated 2026-Q2, anchored at $194.35, EQUIFAX INC (EFX) is priced for +23.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Most of the profit sits in one place: Workforce Solutions, the payroll and income records business, earned a 44.9% operating margin on 705.4 million dollars of revenue in the June quarter, roughly double what the credit bureau alongside it manages [Source: Q2 2026 earnings release, July 21, 2026]. • The clearest risk is written into the annual report, which calls competition in Verification Services ⟦highly competitive with low barriers to entry⟧ and tells investors to expect U.S. mortgage cre
Is EFX overvalued? See what's priced in →
840 institutional managers reported holding EFX in 13F filings for the quarter ended 2026-03-31. 119 opened new positions that quarter. Held by Vanguard Group, BlackRock, Harris Associates (Oakmark), among others. On the short side, 5.8M shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (3.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
EFX has cut its share count 1.5% over the past five years, spending $1.20B on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $1.89 a share annually. Cash returned over the past three years: $589.30M in dividends and $1.20B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at EFX over the trailing three years: 2023: 2 buys totaling $152k; 2024: 1 buy totaling $99k. 25 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
EFX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-26 | -9.0% | -11.2% |
| 2023-10-24 | -1.5% | +45.9% |
| 2024-02-23 | -0.4% | -16.0% |
| 2024-04-23 | -8.8% | +5.8% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
EFX's latest 8-K filings: 2026-07-29 (items 8.01, 9.01); 2026-07-21 (items 2.02, 9.01); 2026-06-16 (items 5.03, 9.01); 2026-05-13 (items 5.07); 2026-04-24 (items 1.01, 2.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.